Cargando…
Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity
In the recent years, the role of LOX enzymes in the origin of neoplastic diseases such as colorectal, skin, pancreatic and renal cancers has been confirmed. A new series of 1,3,4-thiadiazole derivatives bearing 2-pyridyl moiety was synthesized and the cytotoxicity of the members of this series was a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423244/ https://www.ncbi.nlm.nih.gov/pubmed/28496472 |
_version_ | 1783234905713410048 |
---|---|
author | Aliabadi, Alireza Mohammadi-Farani, Ahmad Roodabeh, Sahar Ahmadi, Farahnaz |
author_facet | Aliabadi, Alireza Mohammadi-Farani, Ahmad Roodabeh, Sahar Ahmadi, Farahnaz |
author_sort | Aliabadi, Alireza |
collection | PubMed |
description | In the recent years, the role of LOX enzymes in the origin of neoplastic diseases such as colorectal, skin, pancreatic and renal cancers has been confirmed. A new series of 1,3,4-thiadiazole derivatives bearing 2-pyridyl moiety was synthesized and the cytotoxicity of the members of this series was assessed using MTT protocol. Enzyme inhibitory activity of the prepared compounds was also tested against 15-lipoxygenase-1 as a novel target for the discovery of anticancer drugs. PC3, HT29 and SKNMC cell lines were utilized and the obtained results were compared with doxorubicin. Overall, nitro containing derivatives exerted a higher cytotoxic activity against PC3 cell line and methoxylated derivatives showed an acceptable activity against SKNMC cell line. Methoxylated derivatives were also the most potent enzyme inhibitors especially at position ortho of the phenyl residue. |
format | Online Article Text |
id | pubmed-5423244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-54232442017-05-11 Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity Aliabadi, Alireza Mohammadi-Farani, Ahmad Roodabeh, Sahar Ahmadi, Farahnaz Iran J Pharm Res Original Article In the recent years, the role of LOX enzymes in the origin of neoplastic diseases such as colorectal, skin, pancreatic and renal cancers has been confirmed. A new series of 1,3,4-thiadiazole derivatives bearing 2-pyridyl moiety was synthesized and the cytotoxicity of the members of this series was assessed using MTT protocol. Enzyme inhibitory activity of the prepared compounds was also tested against 15-lipoxygenase-1 as a novel target for the discovery of anticancer drugs. PC3, HT29 and SKNMC cell lines were utilized and the obtained results were compared with doxorubicin. Overall, nitro containing derivatives exerted a higher cytotoxic activity against PC3 cell line and methoxylated derivatives showed an acceptable activity against SKNMC cell line. Methoxylated derivatives were also the most potent enzyme inhibitors especially at position ortho of the phenyl residue. Shaheed Beheshti University of Medical Sciences 2017 /pmc/articles/PMC5423244/ /pubmed/28496472 Text en ©2017 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Aliabadi, Alireza Mohammadi-Farani, Ahmad Roodabeh, Sahar Ahmadi, Farahnaz Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity |
title | Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity |
title_full | Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity |
title_fullStr | Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity |
title_full_unstemmed | Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity |
title_short | Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity |
title_sort | synthesis and biological evaluation of n-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide derivatives as lipoxygenase inhibitor with potential anticancer activity |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423244/ https://www.ncbi.nlm.nih.gov/pubmed/28496472 |
work_keys_str_mv | AT aliabadialireza synthesisandbiologicalevaluationofn5pyridin2yl134thiadiazol2ylbenzamidederivativesaslipoxygenaseinhibitorwithpotentialanticanceractivity AT mohammadifaraniahmad synthesisandbiologicalevaluationofn5pyridin2yl134thiadiazol2ylbenzamidederivativesaslipoxygenaseinhibitorwithpotentialanticanceractivity AT roodabehsahar synthesisandbiologicalevaluationofn5pyridin2yl134thiadiazol2ylbenzamidederivativesaslipoxygenaseinhibitorwithpotentialanticanceractivity AT ahmadifarahnaz synthesisandbiologicalevaluationofn5pyridin2yl134thiadiazol2ylbenzamidederivativesaslipoxygenaseinhibitorwithpotentialanticanceractivity |